Short article: Outcome of medical and surgical management for perforated jejunal diverticulitis
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Arguelles, BG
- Gallardo, CM
- Carreno, O
- Pellino, G
Grupos
Abstract
Objectives Perforated jejunal diverticulitis (PJD) is rare, but it has high mortality rates. The role of nonsurgical management is debated. The aim of this study is to assess the outcomes of medical and surgical management of PJD. Patients and methods A single-centre study on a series of emergency patients diagnosed with PJD between 2010 and 2016 was conducted. Results Eleven patients with PJD were treated (seven women). Nine out of 11 were diagnosed by a computed tomography scan, and two were diagnosed at laparotomy. The initial approach was medical treatment in five patients, based on clinical and imaging findings. Four (80%) of these five patients were discharged without the need for surgical intervention. The median hospital stay was 7.5 days. Seven patients required surgery overall with a median length of hospital stay of 10.8 days. Surgical procedures consisted of segmental bowel resection and primary anastomosis in six patients and simple closure in one. There was no perioperative deaths. One patient required percutaneous drainage because of anastomotic leak, and one required reoperation owing to evisceration. Discussion Selected patients with PJD can be successfully managed with conservative approach, based on clinical and computed tomography findings. Copyright (c) 2018 Wolters Kluwer Health, Inc. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0954-691X, 1473-5687
- Tipo:
- Article
- Páginas:
- 135-139
- Factor de Impacto:
- 0,904 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY LIPPINCOTT WILLIAMS & WILKINS
Citas Recibidas en Web of Science: 2
Documentos
- No hay documentos
Filiaciones
Keywords
- complications; diverticula; diverticulitis; jejunoileal; perforation; small bowel
Proyectos asociados
WIBEC. WIRELESS IN-BODY ENVIRONMENT COMMUNICATIONS.
Investigador Principal: VICENTE PONS BELTRÁN
675353 . COMISION EUROPEA . 2016
MODELOS DE HÍGADO AISLADO PERFUNDIDO PARA EL RESCATE DE ÓRGANOS Y TRASLACIÓN DE LA TERAPIA GÉNICA EN EL TRASPLANTE: ESCENARIOS HUMANO "EX VIVO" Y PORCINO "IN VIVO"
Investigador Principal: RAFAEL LÓPEZ ANDÚJAR
2017_0270_CRC_LOPEZ . FUNDACION MUTUA MADRILEÑA . 2017
Ileostomía vistual combinada con endoscopia postoperatoria ebn cáncer de recto con escisión total mesorrectal. ¿podemos evitar estomas innecesarios? estudio prospectivo observacional multicénctrico.
Investigador Principal: BLAS FLOR LORENTE
PI17/00863 . INSTITUTO DE SALUD CARLOS III . 2018
"TIMing Evaluation of Stoma closure” Cierre precoz vs tardío del estoma derivativo tras cirugía de cáncer de recto.
Investigador Principal: MATTEO FRASSON
2018_0078_CRC_FRASSON . ASOCIACIÓN ESPAÑOLA DE COLOPROCTOLOGÍA (AECP) . 2018
Terápia génica no-viral con 1L 10 para el tratamiento de la enfermedad inflamatoria intestinal. Estudio preliminar con piezas de cólon humano ex vivo.
Investigador Principal: MATTEO FRASSON
PI18/01658 . INSTITUTO DE SALUD CARLOS III . 2019
ESTUDIO PILOTO DEL TRATAMIENTO DEL LIQUEN ESCLEROSO VULVAR MEDIANTE TEJIDO ADIPOSO ASOCIADO A PLASMA RICO EN PLAQUETAS AUTÓLOGO.
Investigador Principal: PATRICIA GUTIERREZ ONTALVILLA
LIQUENIA . 2017
INDIVIDUALIZED PERIOPERATIVE HEMODYNAMIC GOAL-DIRECTED THERAPY IN MAJOR ABDOMINAL SURGERY (IPEGASUS-TRIAL).
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
IPEGASUS . 2017
MU OPIOID RECEPTOR 1 (MOR-1) EXPRESSION IN COLORECTAL CANCER AND DISEASE-FREE SURVIVAL RELATIONSHIP (MOROCCO). FIVE-YEAR FOLLOW-UP.
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
ODC-MOR-2018-01
ESTUDIO OBSERVACIONAL PARA EVALUAR LA ESTRATEGIA DE USO DE LAS TERAPIAS DIRIGIDAS, EN CÁNCER DE COLON METASTÁSICO.
Investigador Principal: JORGE APARICIO URTASUN
GEM-BEV-2013-01 . 2015
Cita
Garcia A,Arguelles BG,Gallardo CM,Carreno O,Giner F,Pellino G,Frasson M. Short article: Outcome of medical and surgical management for perforated jejunal diverticulitis. Eur J Gastroenterol Hepatol. 2019. 31. (1):p. 135-139. IF:2,251. (4).